Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Cytek Biosciences to related businesses based on the strength of its dividends, analyst recommendations, profitability, earnings, institutional ownership, risk and valuation. Institutional & Insider Ownership 36.0% of […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare Cytek Biosciences to similar companies based on the strength of its earnings, profitability, risk, institutional ownership, analyst recommendations, valuation and dividends. Analyst Recommendations This is a breakdown […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Cytek Biosciences to related businesses based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, earnings, risk and valuation. Earnings & Valuation This […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its competitors? We will compare Cytek Biosciences to related businesses based on the strength of its profitability, analyst recommendations, earnings, risk, valuation, institutional ownership and dividends. Valuation and Earnings This table compares […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Cytek Biosciences to similar companies based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk. Earnings & Valuation This […]